Learn more about CERo's vision: #CancerResearch #Immunotherapy #ClinicalTrials To view or add a comment, sign in The TORPEDO trial dropped at ASTRO
To maximize efficacy while minimizing side effects, a common dose escalation regimen in metabolic studies is as follows: Weeks 14: 2 mg weekly (to reduce gastrointestinal side effects) Weeks 58: 4 mg weekly Weeks 912: 8 mg weekly Week 13 onward: 12 mg weekly for optimal results Beyond these metabolic effects, retatrutide is paving the way for exciting advances in tissue repair research
Changing patterns in BTMs and BMD are similar to those found in calorie restriction interventions: CTX levels increased to a greater extent compared to those of PINP, and total hip BMD decreased to a greater extent compared to lumbar spine BMD [35, 36]
Accordingly, despite losing 25% of their body mass, GLP-1MK-801-treated mice maintained an energy expenditure that was similar to that of vehicle-treated control mice and was therefore also significantly higher than the gradually decreasing energy expenditure observed in mice that were calorie-restricted to match the weight loss trajectory of GLP-1MK-801-treated mice
Marcia US 1 review Aug 7, 2025 It was simple, easy, and the communication is great
Prescribing Information: Wegovy, (semaglutide) injection, for subcutaneous use
